PLA2G7 anticorps

N° du produit ABIN7321909

Détail du produit anti-PLA2G7 anticorps

Antigène: PLA2G7 (Lp-PLA2) (Lipoprotein-Associated phospholipase A2 (Lp-PLA2))

Reactivité: Humain

Hôte: Souris

Clonalité: Monoclonal

Conjugué: Cet anticorp PLA2G7 est non-conjugé

Application: Western Blotting (WB), ELISA, Immunohistochemistry (IHC)

Réactivité croisée: Humain, Souris

Purification: Protein G purified

Immunogène: Recombinant LP-PLA2 Protein

Clone: 2A1B6

Isotype: IgG1, IgG1 kappa

Information d'application

Indications d'application: Recommended dilution:WB:1:500-1:5000,IHC:1:50-1:500,

Restrictions: For Research Use only

Stockage

Format: Liquid

Buffer: Preservative: 0.03 % Proclin 300
Constituents: 50 % Glycerol, 0.01M PBS, PH 7.4

Agent conservateur: ProClin

Précaution d'utilisation: This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Stock: -20 °C,-80 °C

Stockage commentaire: Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.

Détails sur PLA2G7

Antigène: PLA2G7 (Lp-PLA2) (Lipoprotein-Associated phospholipase A2 (Lp-PLA2))

Autre désignation: PLA2G7 (Lp-PLA2 Produits)

Synonymes: anticorps LDL-PLA2, anticorps LP-PLA2, anticorps PAFAD, anticorps PAFAH, anticorps Lp-PLA2, anticorps PAF-AH, anticorps R75400, anticorps zgc:77563, anticorps phospholipase A2 group VII, anticorps phospholipase A2, group VII (platelet-activating factor acetylhydrolase, plasma), anticorps PLA2G7, anticorps Pla2g7, anticorps pla2g7

Sujet:

Background: Platelet-activating factor acetylhydrolase deficiency (PAFAD) : An enzymatic deficiency that results in exacerbated bodily response to inflammatory agents. It can be associated with several disease states including inflammatory gastrointestinal disorders, asthma and atopy. Asthmatic individuals with PAFAD may manifest aggravated respiratory symptoms.

Aliases: PLA2G7, PAFAH, LP-PLA2

UniProt: Q13093

Pathways: Peptide Hormone Metabolism